Global Needles Market

Needles Market Size, Share, Growth Analysis, By Product (Suture Needles, Blood Collection Needles), By Type (Conventional Needles, Bevel Needles), By Application, By Delivery, By Material, By End User, By Region - Industry Forecast 2025-2032

Report ID: SQSG35A2036 | Region: Global | Published Date: December, 2024
Pages: 225 | Tables: 94 | Figures: 76

Needles Market News

  • In July 2022, Thermo Fisher Scientific and Hologic both presented updates to their current lineups of respiratory virus tests. The new test panels are originally available in the European Union with CE mark clearance and screen for several prevalent viruses at once, including COVID-19, the flu, the common cold, respiratory syncytial virus, pneumonia, and more.
  • In April 2022, together with a new decentralized clinical trial (DCT) solution, Thermo Fisher Scientific Inc.'s PPD clinical research division and Matrix Clinical Trials, a Matrix Medical Network service, are bringing clinical trials to patients. To assist find, attracting, and retaining trial participants while guaranteeing a favorable patient experience, the company is deploying cutting-edge Matrix mobile research sites and knowledgeable clinical personnel across the U.S. The two businesses are simultaneously looking for ways to extend their partnership to new regions.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Needles Market size was valued at USD 7.6 billion in 2022 and is poised to grow from USD 8.12 billion in 2023 to USD 13.74 billion by 2031, growing at a CAGR of 6.8% during the forecast period (2024-2031).

The global needles market is relatively fragmented, with a high level of competition. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective solutions. 'Becton, Dickinson and Company (BD) (USA) ', 'B. Braun Melsungen AG (Germany) ', 'Terumo Corporation (Japan) ', 'Teleflex Incorporated (USA) ', 'Nipro Corporation (Japan) ', 'Smiths Medical (UK) ', 'Medtronic plc (Ireland) ', 'Stryker Corporation (USA) ', 'Ethicon, Inc. (Subsidiary of Johnson & Johnson) (USA) ', 'Boston Scientific Corporation (USA) ', 'Olympus Corporation (Japan) ', 'Merit Medical Systems, Inc. (USA) ', 'Hamilton Company (USA) ', 'Unimed SA (France) ', 'Argon Medical Devices Inc. (USA) ', 'Greiner Holding AG (Austria) ', 'Merck KGaA (Germany) ', 'Hakko Co.Ltd. (Japan) ', 'DTR Medical (UK)'

During the projected period, the market for needles is anticipated to rise more quickly due to the rising incidence of different chronic diseases and the rising number of hospitals and clinics in developing nations. It is anticipated that major businesses will continue to invest heavily in research and development to bring the most safe and precise needle technology to market. In order to allow surgeons to examine specific blood arteries at danger when placing the needle and prevent deadly bleeding, a research team from the University of Adelaide created a biopsy needle coupled to a tiny imaging probe in January 2018.

In the projection period of 2022 to 2028, an increase in public-private financing for targeted research activities, an increase in the elderly population, and favorable regulatory policies for the approval of novel injectables will expand the market's lucrative potential. In the future, the market's growth rate will be further accelerated by factors such as the rising number of strategic alliances, the internet penetration rate, the expansion of hospitals and laboratories, the rise in drug self-administration, the use of safety needles, and the per capita spending on health care.

The needles market is dominated by North America due to the region's strong base of healthcare facilities, growing investment from major players in the development of cutting-edge devices, well-established distribution networks for needle product manufacturers, and an increase in research activities. For example, in 2021, investors closed 96 Medtech investments, a substantial increase from 55 in 2020 and a record-breaking 60 in 2018. Deal value increased to $40.8 billion from $3 billion in 2020, mostly because of the $34 billion Medline deal. Such fluctuations are typical in the industry, where substantial assets are not as common. Supply chain resilience and cost control, technology for alternative treatment, specialist contract manufacturing, and regulatory assistance are important issues for investors in North America and Europe.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Pen Needles Market
Buy Now GET FREE SAMPLE
Suture Needles Market
Buy Now GET FREE SAMPLE
Safety Needles Market
Buy Now GET FREE SAMPLE
Acupuncture Needles Market
Buy Now GET FREE SAMPLE
Needle-free Drug Delivery Devices Market
Buy Now GET FREE SAMPLE
Catheter Market
Buy Now GET FREE SAMPLE
Injection Pen Market
Buy Now GET FREE SAMPLE
Medical Electrodes Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Needles Market

Report ID: SQSG35A2036

$5,300
BUY NOW GET FREE SAMPLE